デング熱検査の市場規模、シェア、動向分析レポート：製品タイプ別、サービスタイプ別、最終用途別、地域別、セグメント別予測、2025年～2030年

デング熱検査市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のデング熱検査市場規模は2025～2030年にかけてCAGR 5.22%を記録し、2030年には8億2,261万米ドルに達する見込みです。

都市化、気候変動、海外旅行の増加などの要因により、デング熱感染の主要な媒介蚊であるイエネコの生息地が拡大しています。例えば、2023年にはインドで30万人近いデング熱患者が報告され、アジア太平洋におけるデング熱の流行が拡大していることが明らかになりました。このような罹患率の増加により、早期発見と迅速な治療を可能にする効率的な診断ツールの開発と展開が必要となり、それによってこの病気に関連する罹患率と死亡率を減らすことができます。

診断技術の革新により、デング熱検出の精度とスピードは大幅に向上しています。酵素結合免疫吸着測定法（ELISA）、逆転写ポリメラーゼ連鎖反応（RT-PCR）、迅速抗原検査などの先進的方法の導入は、このセグメントに革命をもたらしました。これらの技術は感度と特異性が高く、ヘルスケア提供者はデング熱感染を迅速に診断できます。さらに、ポイントオブケア検査機器の開発により、遠隔地や資源が限られた環境では極めて重要な現場での診断が容易になりました。このような進歩は、患者の予後を改善するだけでなく、感染拡大の抑制にも貢献します。

政府や国際的な取り組みは、デング熱検査市場を強化する上で極めて重要な役割を果たしています。2024年8月、米国国際開発庁（USAID）は、地域のアウトブレイク対応を強化するため、2万米ドル相当のデングウイルスとその他のアルボウイルス検査キットをカリブ海公衆衛生局（CARPHA）に寄贈しました。このようなイニシアチブは、脆弱な地域における診断能力強化へのコミットメントを強調するものです。さらに、米国食品医薬品局（FDA）のような規制機関は、2024年12月に特別510（k）認可を取得したバイオメリューのBIOFIRE FILMARRAY熱帯熱パネルのような革新的な診断ソリューションの認可を迅速化しています。このような協調的な取り組みにより、先進的な診断ツールの世界の普及と利用が促進されます。

デング熱とその影響に関する意識の高まりは、診断検査に対する需要の増加につながりました。公衆衛生キャンペーンや教育プログラムは、デング熱の症状、感染、予防について地域社会に情報を提供するのに役立っています。このような認識により、人々は適時に医療機関を受診するようになり、効率的な診断サービスが必要となります。さらに、情報を得た地域社会は、媒介蚊の駆除活動に参加しやすくなり、間接的に疾病管理に貢献することになります。このように、教育と啓発の重視は、診断薬市場の牽引役として重要な役割を果たしています。

迅速診断検査（RDT）キットの開発と入手可能性は、特に流行地域におけるデング熱検出を一変させました。これらのキットは、多くの場合数分以内に迅速な結果を提供し、即座の臨床判断を容易にします。Fujifilmは2023年8月、独自の銀増幅技術を活用した画期的なデング熱NS1抗原検査キットを発売し、早期診断を可能にしました。このような技術革新は、疾患の重症度を軽減し、死亡率を低下させる上で極めて重要です。RDTの利便性、手頃な価格、効率性は、デング熱との世界の闘いにおいて不可欠なツールとなっており、市場の成長を促進しています。

デング熱検査市場のレポートハイライト

• 製品別では、ELISAベースの検査セグメントが2024年に44.94%の最大市場シェアを占め、高感度、特異性、デング抗原（NS1）と抗体（IgMとIgG）の両方を検出する能力がその原動力となっています。
• サービスタイプ別では、正確で包括的な検査ソリューションに対する需要の高まりにより、集中型サービスセグメントが2024年の売上シェア59.93%で市場をリードしました。主に病院や診断センターに設置されている集中型ラボは、デング熱感染の確認に不可欠なELISA検査やRT-PCR検査などの先進的診断機能を提供しています。
• 最終用途別では、臨床検査部門が2024年の売上高シェア44.16％で市場を独占しています。成長の原動力は、検査室の自動化、高スループットELISA、RT-PCRプラットフォームへの投資の増加であり、これにより即日対応が可能になりました。
• 2024年には、インド、インドネシア、タイにおけるデング熱の流行により、アジア太平洋が31.57%のシェアで世界市場をリードしました。国のベクタコントロールプログラム（例えばインドのNVBDCP）は、地域のラボでELISAとRT-PCRに資金を提供し、地域の保健センターはPOC NS1迅速検査を配備しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 デング熱検査市場の変数、動向、範囲

• 市場セグメンテーションと範囲
• 市場系統の展望
  • 親市場の展望
  • 関連/補助市場展望
• 市場動向と展望
• 市場力学
  • デング熱の発生率の上昇
  • 技術の進歩
  • 政府と国際的な取り組み
• 市場抑制要因分析
  • 診断検査の高額な費用
  • ヘルスケアインフラへのアクセスが限られている
  • ポーターのファイブフォース分析
  • PESTEL分析

第4章 デング熱検査市場：製品別、推定・動向分析

• デング熱検査市場：製品変動分析
• 製品別
• ELISAベースの検査
• デング熱IgG/IgM検出キット
• RT-PCR検査
• 迅速診断検査（RDT）
• NS1抗原検出キット
• ラテラルフロー免疫測定

第5章 デング熱検査市場：サービスタイプ別、推定・動向分析

• デング熱検査市場：サービスタイプ変動分析
• サービスタイプ別
• 集中型サービス
• POCサービス

第6章 デング熱検査市場：最終用途別、推定・動向分析

• デング熱検査市場：最終用途変動分析
• 最終用途別
• 臨床検査室
• 病院/クリニック
• 在宅ヘルスケア

第7章 デング熱検査市場：地域別、推定・動向分析

• デング熱検査市場シェア（地域別）、2024年と2030年
• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 世界地域市場のスナップショット
• 市場規模、予測動向分析、2018～2030年
• 北米
  • 北米のデング熱検査市場、2018～2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州のデング熱検査市場、2018～2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • アジア太平洋のデング熱検査市場、2018～2030年
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ラテンアメリカのデング熱検査市場、2018～2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカのデング熱検査市場、2018～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業分類
• 戦略マッピング
• 企業市場シェア分析、2024年
• 企業プロファイル
  • Thermo Fisher Scientific Inc.
  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • InBios International, Inc.
  • NovaTec Immundiagnostica GmbH
  • Abnova Corporation
  • PerkinElmer Inc.（Euroimmun AG）
  • Certest BIoTec
  • DiaSorin SpA
  • Quest Diagnostics Incorporated

List of Tables

• Table 1 List of abbreviations
• Table 2 Global Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 3 Global Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 4 Global Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 5 Global Dengue Testing Market, by Region, 2018 - 2030 (USD Million)
• Table 6 North America Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
• Table 7 North America Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 8 North America Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 9 North America Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 10 U.S. Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 11 U.S. Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 12 U.S. Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 13 Canada Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 14 Canada Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 15 Canada Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 16 Mexico Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 17 Mexico Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 18 Mexico Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 19 Europe Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
• Table 20 Europe Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 21 Europe America Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 22 Europe America Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 23 UK Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 24 UK Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 25 UK Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 26 Germany Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 27 Germany Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 28 Germany Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 29 France Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 30 France Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 31 France Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 32 Italy Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 33 Italy Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 34 Italy Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 35 Spain Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 36 Spain Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 37 Spain Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 38 Denmark Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 39 Denmark Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 40 Denmark Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 41 Sweden Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 42 Sweden Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 43 Sweden Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 44 Norway Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 45 Norway Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 46 Norway Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 51 Japan Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 52 Japan Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 53 Japan Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 54 China Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 55 China Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 56 China Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 57 India Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 58 India Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 59 India Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 60 Australia Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 61 Australia Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 62 Australia Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 63 Thailand Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 64 Thailand Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 65 Thailand Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 66 South Korea Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 67 South Korea Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 68 South Korea Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 69 Latin America Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
• Table 70 Latin America Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 71 Latin America Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 72 Latin America Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 73 Brazil Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 74 Brazil Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 75 Brazil Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 76 Argentina Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 77 Argentina Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 78 Argentina Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa Dengue Testing Market, by Country, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa Dengue Testing Market, by product, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 83 South Africa Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 84 South Africa Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 85 South Africa Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 89 UAE Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 90 UAE Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 91 UAE Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)
• Table 92 Kuwait Dengue Testing Market, by Product, 2018 - 2030 (USD Million)
• Table 93 Kuwait Dengue Testing Market, by Service Type, 2018 - 2030 (USD Million)
• Table 94 Kuwait Dengue Testing Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value chain-based sizing & forecasting
• Fig. 6 Market formulation & validation
• Fig. 7 Dengue Testing Market segmentation
• Fig. 8 Market snapshot, 2024
• Fig. 9 Market trends & outlook
• Fig. 10 Market driver relevance analysis (current & future impact)
• Fig. 11 Market restraint relevance analysis (current & future impact)
• Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
• Fig. 13 Porter's five forces analysis
• Fig. 14 Dengue testing market: Product movement analysis
• Fig. 15 Dengue testing market: Product outlook and key takeaways
• Fig. 16 ELISA-based Tests market estimates and forecast, 2018 - 2030
• Fig. 17 Dengue IgG/IgM Detection Kits market estimates and forecast, 2018 - 2030
• Fig. 18 RT-PCR Tests market estimates and forecast, 2018 - 2030
• Fig. 19 Rapid Diagnostic Tests (RDTs) market estimates and forecast, 2018 - 2030
• Fig. 20 NS1 Antigen Detection Kits market estimates and forecast, 2018 - 2030
• Fig. 21 Lateral Flow Immunoassay market estimates and forecast, 2018 - 2030
• Fig. 22 Dengue testing market: Service Type movement analysis
• Fig. 23 Dengue testing market: Service Type outlook and key takeaways
• Fig. 24 Centralized Service market estimates and forecast, 2018 - 2030
• Fig. 25 POC Service market estimates and forecast, 2018 - 2030
• Fig. 26 Dengue testing market: End use movement analysis
• Fig. 27 Dengue testing market: End use outlook and key takeaways
• Fig. 28 Clinical Labs market estimates and forecast, 2018 - 2030
• Fig. 29 Hospitals /Clinics market estimates and forecast, 2018 - 2030
• Fig. 30 Home Healthcare market estimates and forecast, 2018 - 2030
• Fig. 31 Government Suppliers market estimates and forecast, 2018 - 2030
• Fig. 32 Others market estimates and forecast, 2018 - 2030
• Fig. 33 Regional outlook, 2024 & 2030
• Fig. 34 Global Dengue Testing Market: Region movement analysis
• Fig. 35 North America Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 36 U.S. Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 37 Canada Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 38 Mexico Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 39 Europe Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 40 Germany Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 41 UK Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 42 France Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 43 Italy Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 44 Spain Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 45 Denmark Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 46 Sweden Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 47 Norway Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 48 Asia Pacific Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 49 Japan Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 50 China Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 51 India Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 52 Australia Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 53 South Korea Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 54 Thailand Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 55 Latin America Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 56 Brazil Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 57 Argentina Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 58 Middle East and Africa Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 59 South Africa Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 60 Saudi Arabia Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 61 UAE Dengue Testing Market, 2018 - 2030 (USD Million)
• Fig. 62 Kuwait Dengue Testing Market, 2018 - 2030 (USD Million)

Dengue Testing Market Growth & Trends:

The global dengue testing market size is expected to reach USD 822.61 million by 2030, registering a CAGR of 5.22% from 2025 to 2030, according to a new report by Grand View Research, Inc. Factors such as urbanization, climate change, and increased international travel have expanded the habitats of Aedes mosquitoes, the primary vectors for dengue transmission. For instance, in 2023, India reported nearly 300,000 dengue cases, highlighting the disease's growing prevalence in Asia-Pacific region. This escalating incidence necessitates the development and deployment of efficient diagnostic tools to enable early detection and prompt treatment, thereby reducing morbidity and mortality associated with the disease.

Innovations in diagnostic technologies have significantly improved the accuracy and speed of dengue detection. The introduction of advanced methods such as enzyme-linked immunosorbent assays (ELISA), reverse transcription-polymerase chain reaction (RT-PCR), and rapid antigen tests has revolutionized the field. These technologies offer high sensitivity and specificity, enabling healthcare providers to diagnose dengue infections promptly. Moreover, the development of point-of-care testing devices facilitates on-site diagnostics, crucial in remote or resource-limited settings. Such advancements not only enhance patient outcomes but also contribute to controlling the spread of the disease.

Governmental and international efforts play a pivotal role in bolstering the dengue testing market. In August 2024, the United States Agency for International Development (USAID) donated dengue and other arbovirus test kits, valued at USD 20,000, to the Caribbean Public Health Agency (CARPHA) to enhance regional outbreak response. Such initiatives underscore the commitment to strengthening diagnostic capacities in vulnerable regions. Additionally, regulatory bodies like the U.S. Food and Drug Administration (FDA) have expedited the approval of innovative diagnostic solutions, such as bioMerieux's BIOFIRE FILMARRAY Tropical Fever Panel, which received Special 510(k) clearance in December 2024. These concerted efforts facilitate the availability and adoption of advanced diagnostic tools globally.

Heightened awareness about dengue fever and its implications has led to increased demand for diagnostic testing. Public health campaigns and educational programs have been instrumental in informing communities about the symptoms, transmission, and prevention of dengue. This awareness encourages individuals to seek timely medical attention, thereby necessitating efficient diagnostic services. Furthermore, informed communities are more likely to participate in vector control initiatives, indirectly contributing to disease management. The emphasis on education and awareness thus plays a critical role in driving the diagnostics market.

The development and availability of rapid diagnostic test (RDT) kits have transformed dengue detection, especially in endemic regions. These kits offer quick results, often within minutes, facilitating immediate clinical decisions. In August 2023, Fujifilm launched its revolutionary Dengue NS1Ag Test Kit, utilizing proprietary silver amplification technology to enable early diagnosis. Such innovations are crucial in mitigating disease severity and reducing mortality rates. The convenience, affordability, and efficiency of RDTs make them indispensable tools in the global fight against dengue, thereby propelling market growth.

Dengue Testing Market Report Highlights:

• Based on product, the ELISA-based tests segment accounted for the largest market share of 44.94% in 2024, driven by their high sensitivity, specificity, and ability to detect both dengue antigens (NS1) and antibodies (IgM and IgG).
• Based on service type, the centralized service segment led the market with a 59.93% revenue share in 2024, driven by the increasing demand for accurate and comprehensive testing solutions. Centralized laboratories, primarily located in hospitals and diagnostic centers, offer advanced diagnostic capabilities, including ELISA and RT-PCR tests, which are essential for confirming dengue infections
• Based on end use, the clinical labs segment dominated the market with a revenue share of 44.16% in 2024. Growth is driven by increased investments in laboratory automation, high?throughput ELISA, and RT?PCR platforms, enabling same?day turnaround.
• In 2024, Asia Pacific led the global market with a share of 31.57%, owing to endemic dengue transmission in India, Indonesia, and Thailand. National vector control programs (e.g., India's NVBDCP) fund ELISA and RT?PCR in regional labs, while community health centers deploy POC NS1 rapid tests.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Service Type
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Service Type outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Dengue Testing Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Trends and Outlook
• 3.4. Market Dynamics
  • 3.4.1. Rising Incidence of Dengue
  • 3.4.2. Technological Advancements
  • 3.4.3. Government and International Initiatives
• 3.5. Market Restraint Analysis
  • 3.5.1. High Cost of Diagnostic Tests
  • 3.5.2. Limited Access to Healthcare Infrastructure
  • 3.5.3. Porter's Five Forces Analysis
  • 3.5.4. PESTEL Analysis

Chapter 4. Dengue Testing Market: Product Estimates & Trend Analysis

• 4.1. Dengue Testing Market: Product Movement Analysis
• 4.2. Dengue Testing Market Estimates and Forecast, by Product
• 4.3. ELISA-based Tests
  • 4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.4. Dengue IgG/IgM Detection Kits
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. RT-PCR Tests
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Rapid Diagnostic Tests (RDTs)
  • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. NS1 Antigen Detection Kits
  • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Lateral Flow Immunoassay
  • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Dengue Testing Market: Service Type Estimates & Trend Analysis

• 5.1. Dengue Testing Market: Service Type Movement Analysis
• 5.2. Dengue Testing Market Estimates and Forecast, by Service Type
• 5.3. Centralized Service
  • 5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.4. POC Service
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Dengue Testing Market: End Use Estimates & Trend Analysis

• 6.1. Dengue Testing Market: Distribution Movement Analysis
• 6.2. Dengue Testing Market Estimates and Forecast, by End Use
• 6.3. Clinical Labs
  • 6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.4. Hospitals /Clinics
  • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Home Healthcare
  • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Dengue Testing Market: Regional Estimates & Trend Analysis

• 7.1. Dengue Testing Market Share By Region, 2024 & 2030
• 7.2. Regional Market Share Analysis, 2024 & 2030
• 7.3. Regional Market Dashboard
• 7.4. Global Regional Market Snapshot
• 7.5. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.6. North America
  • 7.6.1. North America Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.6.2. U.S.
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. U.S. Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.6.3. Canada
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Canada Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.6.4. Mexico
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Mexico Dengue Testing Market, 2018 - 2030 (USD Million)
• 7.7. Europe
  • 7.7.1. Europe Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.7.2. UK
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. UK Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.7.3. Germany
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Germany Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.7.4. France
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. France Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.7.5. Italy
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Italy Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.7.6. Spain
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Competitive Scenario
    • 7.7.6.3. Regulatory Framework
    • 7.7.6.4. Spain Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.7.7. Denmark
    • 7.7.7.1. Key Country Dynamics
    • 7.7.7.2. Competitive Scenario
    • 7.7.7.3. Regulatory Framework
    • 7.7.7.4. Denmark Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.7.8. Sweden
    • 7.7.8.1. Key Country Dynamics
    • 7.7.8.2. Competitive Scenario
    • 7.7.8.3. Regulatory Framework
    • 7.7.8.4. Sweden Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.7.9. Norway
    • 7.7.9.1. Key Country Dynamics
    • 7.7.9.2. Competitive Scenario
    • 7.7.9.3. Regulatory Framework
    • 7.7.9.4. Norway Dengue Testing Market, 2018 - 2030 (USD Million)
• 7.8. Asia Pacific
  • 7.8.1. Asia Pacific Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.8.2. Japan
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Japan Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.8.3. China
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. China Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.8.4. India
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. India Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.8.5. Australia
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Australia Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.8.6. Thailand
    • 7.8.6.1. Key Country Dynamics
    • 7.8.6.2. Competitive Scenario
    • 7.8.6.3. Regulatory Framework
    • 7.8.6.4. Thailand Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.8.7. South Korea
    • 7.8.7.1. Key Country Dynamics
    • 7.8.7.2. Competitive Scenario
    • 7.8.7.3. Regulatory Framework
    • 7.8.7.4. South Korea Dengue Testing Market, 2018 - 2030 (USD Million)
• 7.9. Latin America
  • 7.9.1. Latin America Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.9.2. Brazil
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Competitive Scenario
    • 7.9.2.3. Regulatory Framework
    • 7.9.2.4. Brazil Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.9.3. Argentina
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Competitive Scenario
    • 7.9.3.3. Regulatory Framework
    • 7.9.3.4. Argentina Dengue Testing Market, 2018 - 2030 (USD Million)
• 7.10. MEA
  • 7.10.1. MEA Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.10.2. South Africa
    • 7.10.2.1. Key Country Dynamics
    • 7.10.2.2. Competitive Scenario
    • 7.10.2.3. Regulatory Framework
    • 7.10.2.4. South Africa Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.10.3. Saudi Arabia
    • 7.10.3.1. Key Country Dynamics
    • 7.10.3.2. Competitive Scenario
    • 7.10.3.3. Regulatory Framework
    • 7.10.3.4. Saudi Arabia Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.10.4. UAE
    • 7.10.4.1. Key Country Dynamics
    • 7.10.4.2. Competitive Scenario
    • 7.10.4.3. Regulatory Framework
    • 7.10.4.4. UAE Dengue Testing Market, 2018 - 2030 (USD Million)
  • 7.10.5. Kuwait
    • 7.10.5.1. Key Country Dynamics
    • 7.10.5.2. Competitive Scenario
    • 7.10.5.3. Regulatory Framework
    • 7.10.5.4. Kuwait Dengue Testing Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Strategy Mapping
• 8.4. Company Market Share Analysis, 2024
• 8.5. Company Profiles
  • 8.5.1. Thermo Fisher Scientific Inc.
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.5.1.3. Product Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. Abbott
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.5.2.3. Product Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. F. Hoffmann-La Roche Ltd.
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.5.3.3. Product Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. InBios International, Inc.
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.5.4.3. Product Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. NovaTec Immundiagnostica GmbH
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.5.5.3. Product Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. Abnova Corporation
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.5.6.3. Product Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. PerkinElmer Inc. (Euroimmun AG)
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic Initiatives
  • 8.5.8. Certest Biotec
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic Initiatives
  • 8.5.9. DiaSorin S.p.A.
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic Initiatives
  • 8.5.10. Quest Diagnostics Incorporated
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic Initiatives